Cortical Thinning of Motor and Non-Motor Brain Regions Enables Diagnosis of Amyotrophic Lateral Sclerosis and Supports Distinction between Upper- and Lower-Motoneuron Phenotypes.

amyotrophic lateral sclerosis cortical thinning lower motoneuron multivariate analysis upper motoneuron

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
10 Sep 2021
Historique:
received: 01 08 2021
revised: 29 08 2021
accepted: 06 09 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 29 9 2021
Statut: epublish

Résumé

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder clinically characterized by muscle atrophy and progressive paralysis. In addition to the classical ALS affecting both the upper and lower motoneurons (UMN and LMN), other subtypes with the predominant (or even exclusive) affection of the UMN or LMN have been identified. This work sought to detect specific patterns of cortical brain atrophy in the UMN and LMN phenotypes to distinguish these two forms from the healthy state. Using high-resolution structural MRI and cortical thickness analysis, 38 patients with a diagnosis of ALS and predominance of either the UMN ( Significant cortical thinning in the temporal lobe was found in both the ALS groups. Additionally, UMN patients displayed a significant thinning of the cortical thickness in the pre- and postcentral gyrus, as well as the paracentral lobule. By applying multivariate analyses based on the cortical thicknesses of 34 brain regions, ALS patients with either a predominant UMN or LMN phenotype were distinguished from healthy controls with an accuracy of 94% and UMN from LMN patients with an accuracy of 75%. These findings support previous hypothesis that neural degeneration in ALS is not confined to the sole motor regions. In addition, the amount of cortical thinning in the temporal lobe helps to distinguish ALS patients from healthy controls, that is, to support or discourage the diagnosis of ALS, while the cortical thickness of the precentral gyrus specifically helps to distinguish the UMN from the LMN phenotype.

Sections du résumé

BACKGROUND BACKGROUND
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder clinically characterized by muscle atrophy and progressive paralysis. In addition to the classical ALS affecting both the upper and lower motoneurons (UMN and LMN), other subtypes with the predominant (or even exclusive) affection of the UMN or LMN have been identified. This work sought to detect specific patterns of cortical brain atrophy in the UMN and LMN phenotypes to distinguish these two forms from the healthy state.
METHODS METHODS
Using high-resolution structural MRI and cortical thickness analysis, 38 patients with a diagnosis of ALS and predominance of either the UMN (
RESULTS RESULTS
Significant cortical thinning in the temporal lobe was found in both the ALS groups. Additionally, UMN patients displayed a significant thinning of the cortical thickness in the pre- and postcentral gyrus, as well as the paracentral lobule. By applying multivariate analyses based on the cortical thicknesses of 34 brain regions, ALS patients with either a predominant UMN or LMN phenotype were distinguished from healthy controls with an accuracy of 94% and UMN from LMN patients with an accuracy of 75%.
CONCLUSIONS CONCLUSIONS
These findings support previous hypothesis that neural degeneration in ALS is not confined to the sole motor regions. In addition, the amount of cortical thinning in the temporal lobe helps to distinguish ALS patients from healthy controls, that is, to support or discourage the diagnosis of ALS, while the cortical thickness of the precentral gyrus specifically helps to distinguish the UMN from the LMN phenotype.

Identifiants

pubmed: 34572380
pii: biomedicines9091195
doi: 10.3390/biomedicines9091195
pmc: PMC8468309
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : German Research Foundation
ID : SFB 874-TP A8

Références

Neurology. 2010 Nov 2;75(18):1645-52
pubmed: 21041787
J Neurol Sci. 1999 Oct 31;169(1-2):13-21
pubmed: 10540002
J Neurol. 2013 Nov;260(11):2856-64
pubmed: 23996101
J Neurol. 2014 Oct;261(10):1871-80
pubmed: 25022938
Neuroepidemiology. 2015;44(1):6-15
pubmed: 25571962
J Neurol Sci. 2017 Oct 15;381:119-125
pubmed: 28991661
Front Aging Neurosci. 2020 Nov 26;12:593526
pubmed: 33324193
Clin Neurophysiol. 2019 Aug;130(8):1455-1459
pubmed: 31164256
Cortex. 2020 Oct;131:284-294
pubmed: 32811660
PLoS One. 2012;7(8):e42816
pubmed: 22880116
Eur J Radiol. 2020 Mar;124:108815
pubmed: 31945675
Clin Neurophysiol. 2016 Jul;127(7):2643-60
pubmed: 27291884
J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):288-94
pubmed: 25121571
Neuroimage Clin. 2015 Mar 14;7:782-7
pubmed: 25844330
AJNR Am J Neuroradiol. 2012 Jun;33(6):1102-8
pubmed: 22300932
Nat Rev Neurol. 2014 Nov;10(11):661-70
pubmed: 25311585
Int J Mol Sci. 2020 May 21;21(10):
pubmed: 32455692
Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):153-174
pubmed: 28054827
Sci Rep. 2019 Dec 27;9(1):20059
pubmed: 31882886
Neuroimage Clin. 2018 May 17;19:675-682
pubmed: 30023173
Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9
pubmed: 11464847
Neurology. 2015 Nov 17;85(20):1780-8
pubmed: 26497991
Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun;15(3-4):235-43
pubmed: 24344910
Cold Spring Harb Perspect Med. 2017 Aug 1;7(8):
pubmed: 28003278
Neurotoxicology. 2018 Jan;64:60-67
pubmed: 28803850
Eur J Neurol. 2021 May;28(5):1528-1536
pubmed: 33404153
Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):85-92
pubmed: 26458122
Lancet Neurol. 2014 Dec;13(12):1228-40
pubmed: 25453462
Rev Neurol (Paris). 2020 May;176(5):301-315
pubmed: 32147204

Auteurs

Stefano Ferrea (S)

Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University Dusseldorf, 40225 Dusseldorf, Germany.

Frederick Junker (F)

Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University Dusseldorf, 40225 Dusseldorf, Germany.

Mira Korth (M)

Evangelisches Krankenhaus Hattingen, 45525 Hattingen, Germany.

Kai Gruhn (K)

Neuro Center Mettmann, 40822 Mettmann, Germany.

Torsten Grehl (T)

ALS Outpatient Clinic, Alfried Krupp Krankenhaus Rüttenscheid, 45131 Essen, Germany.

Tobias Schmidt-Wilcke (T)

Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University Dusseldorf, 40225 Dusseldorf, Germany.
Neurologisches Zentrum, Bezirksklinikum Mainkofen, 94469 Deggendorf, Germany.

Classifications MeSH